info@biomedres.us   +1 (720) 414-3554   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Opinion Open Access

The Use of Scan Pet for Lung Cancer

Volume 1 - Issue 4

Daniela Vazquez Capdepon*

DOI: 10.26717/BJSTR.2017.01.000124

  • Author Information Open or Close
    • Medical Director of the Centro Oncológico campana, Argentina

    *Corresponding author: Daniela Vazquez Capdepón, Medical Director of the Centro Oncológico campana, Oncologist of the Perú Hospital Gral. Galarza, Oncologist of the Centro Medico San José, French 374 – Campana, Pacia. BS. AS.

Received: June 06, 2017   Published: June 09, 2017

To view the Full Article   Peer-reviewed Article PDF

Abstract

Lung cancer is the most common cause of cancer death in Western countries, and non-small cell lung cancer (NSCLC) accounts for 80% of these neoplasms. Despite the efforts in the early diagnosis and advances in the treatment of these patients, overall survival remains very low, approximately 18% at 5 years2. The relatively low (30-50%) survival of patients with limited, potentially curable disease probably reflects the inability to detect advanced disease at initial staging

Opinion | Conclusion | Figures |